Hospital News and Research

RSS

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

A randomized trial found that video-based, telehealth-delivered exercise and weight loss programs with online educational support improved pain and function in people with knee osteoarthritis and overweight or obesity.

30 Nov 2021

New method helps correct genetic alterations in the cultured patient cells rapidly

Researchers in the University of Helsinki and University Hospital Helsinki have developed a method to precisely and rapidly correct genetic alterations in the cultured patient cells.

30 Nov 2021

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems.

30 Nov 2021

Improving access to health care is key to reducing HIV incidence

Many patients living with HIV in rural Africa are not receiving regular treatment, despite recent efforts to increase access to health care across the continent.

30 Nov 2021

$Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients$

Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients

A research team from the Graduate School of Medicine at Osaka University has started an investigator-initiated clinical trial of sodium astatine ([211At]NaAt) injection for refractory differentiated thyroid cancer patients.

29 Nov 2021

Cytomegalovirus herpesvirus can accelerate the decline of the immune system, study finds

A research team at the University of Córdoba is studying the alterations that occur in the immune system's T lymphocytes with respect to age and in relation to the cytomegalovirus herpesvirus.

29 Nov 2021

Saliva samples are effective and much friendlier way to measure SARS-CoV-2-specific antibodies

Saliva samples are easy to obtain and useful for measuring antibodies to SARS-CoV-2 in children, which could facilitate epidemiological surveillance in school settings.

29 Nov 2021

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

Funded by a Specialized Program of Research Excellence award from the National Cancer Institute (NCI), the Kidney Cancer Program at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center reports the largest and most diverse catalog of kidney cancer tumor models to date.

29 Nov 2021

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Researchers attempt to predict future transmission rates by identifying multiple scenarios that could occur over the next year.

29 Nov 2021

NYU Langone opens new state-of-the-art center to treat patients with blood cancers

NYU Langone Health's Laura and Isaac Perlmutter Cancer Center opened a new state-of-the-art center to treat people with blood cancers, including leukemia, lymphoma, and multiple myeloma.

29 Nov 2021

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.

29 Nov 2021

Study uncovers mechanism for insensitivity to key antimalarial drug in new pathogen variant

Malaria is one of the most dangerous infectious diseases. The causative pathogens are microorganisms of the genus Plasmodium.

29 Nov 2021

Assessing optimal stroke treatment using CTA imaging

Professor Gilberto Gonzalez discusses using a common imaging technique to decide on the best course of treatment for large vessel occlusion stroke patients.

29 Nov 2021

Study shows plasmacytoid dendritic cells may be a viable target for protection against SARS-CoV-2

A recent research paper by scientists from Denmark reveals that circulating plasmacytoid dendritic cells may be a potential therapeutic target to maintain desired levels of an antiviral compound known as interferon, allowing for the mitigation of coronavirus disease (COVID-19) severity. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.

28 Nov 2021

Hospital News and Research

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

New method helps correct genetic alterations in the cultured patient cells rapidly

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

Improving access to health care is key to reducing HIV incidence

Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients

Cytomegalovirus herpesvirus can accelerate the decline of the immune system, study finds

Saliva samples are effective and much friendlier way to measure SARS-CoV-2-specific antibodies

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

NYU Langone opens new state-of-the-art center to treat patients with blood cancers

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

Study uncovers mechanism for insensitivity to key antimalarial drug in new pathogen variant

Assessing optimal stroke treatment using CTA imaging

Study shows plasmacytoid dendritic cells may be a viable target for protection against SARS-CoV-2

SARS-CoV-2 Omicron variant: What we know so far

Viral RNA in the blood found to be a reliable indicator of COVID-19 mortality risk

Tech platforms launch new interactive features to help boost vaccine uptake

Prediction of severe infection based on SARS-CoV-2 genomic analysis

Prevalence of menstrual changes following vaccination against COVID-19

Post-discharge healthcare use of pediatric COVID-19 patients compared to pediatric RTIs patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News